難聴疾患治療の市場規模、シェア、動向分析レポート：製品タイプ別、疾患タイプ別、最終用途別、地域別、セグメント別予測、2024年～2030年

難聴疾患治療市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、難聴疾患治療の世界市場規模は2024年から2030年にかけてCAGR 5.25％を記録し、2030年には193億6,000万米ドルに達する見込みです。

この成長の背景には、世界の疾病負担の増加、人々の意識を広めるために政府や民間団体が行っている取り組み、世界における老人人口の増加があります。さらに、臨床パイプライン医薬品の増加や聴覚デバイスの進歩は、業界の成長に有利な機会を提供します。世界では難聴患者が増加しており、これが業界の成長を促進する主な要因となっています。

例えば、WHOの報告によると、2021年には世界人口の5%以上、約4億3,000万人が聴力障害を管理するためのリハビリテーションを必要とします。さらに、2050年には世界中で約25億人が聴力障害の影響を受けると推定されています。報告書によると、低・中所得国が障害に苦しむ人々の80％を占めています。高齢化がさらに有病率の上昇につながっています。世界全体では、60歳の約25％が難聴に罹患しています。従って、疾病の増加は治療に対する需要を高め、この分野を牽引しています。この分野には強固な臨床試験パイプラインが存在し、今後数年間でより良い治療オプションが提供されると期待されています。

これは、臨床試験のさまざまな段階にある45以上の治療法の存在によって予想されます。例えば、Sound Pharmaceuticals社のEbselenとSensorion社のSENS-401は、それぞれメニエール病と感音性難聴の治療を適応とする第3相臨床試験中です。同様に2022年6月には、パイプライン・セラピューティクス社の第2相試験薬PIPE-505が感音性難聴を対象に評価されています。したがって、今後数年間における新たな治療オプションの発売は、業界に有利な機会を提供すると予想されます。聴覚製品におけるAI関連イノベーションなどの技術進歩の高まりが業界を後押ししています。

スマートフォンでの操作や充電式＆防水デバイスなど、高度な機能を備えた製品の発売は、顧客体験を向上させています。例えば、GNヒアリングは2022年6月、AndroidやiOSからのワイヤレスストリーミングに対応した充電式補聴器「Custom made by Resound」を発売しました。主要企業は、新発売、提携、契約、財務投資などの戦略的イニシアチブを実施しており、これが業界をさらに牽引しています。例えば、2022年4月、オーティジェンはベーリンガーインゲルハイムと、感音性疾患に苦しむ人々のための先進的な治療法を開発するための共同研究およびライセンシング契約を締結しました。同様に、2022年9月、Fennec Pharmaceuticalsは、Pedmarktoが化学療法を受ける小児患者の難聴を防ぐというFDAの承認を発表しました。

難聴疾患治療市場レポートハイライト

• 2023年にはデバイス分野が業界を支配し、全体の収益の90.65%以上の最大シェアを占めました。これは、デバイスの技術的進歩、デバイスの利点の高まりと相まって高い普及率に起因します。
• 薬剤セグメントは、新しい治療製品の発売により、予測期間中に最も速いCAGRを記録すると推定されています。薬剤はいくつかのタイプの聴覚障害に利用可能です。
• 感音性難聴分野は2023年に業界を支配し、総収入の57.04％以上の最大シェアを占め、収益と予測期間で最も急成長する分野と推定・予測されています。
• 耳科クリニックのエンドユーザーセグメントは、2023年に全体の収益の45.18％と2番目に高いシェアを占めました。
• アジア太平洋地域は、対象患者数の増加と同地域の主要プレーヤーへの資金援助により、2024年から2030年にかけて最も急成長する地域と予想されます。

目次

第1章 調査手法

第2章 市場の定義

第3章 エグゼクティブサマリー

第4章 世界の難聴疾患治療市場の変数、動向、および範囲

• 難聴疾患治療市場の系統展望
  • 親市場の見通し
• 普及と成長の見通しのマッピング
• 規制の枠組み
• 市場促進要因分析
  • 難聴の有病率の上昇
  • 強力な研究開発パイプライン
  • 人々の意識の高まり
• 市場抑制要因分析
  • 低中所得国における貧弱な償還制度
• ポーターのファイブフォース分析
• パイプライン分析

第5章 難聴疾患治療市場 - セグメント分析、製品別、2018年～2030年

• 世界の難聴疾患治療市場：製品変動分析
• デバイス
  • デバイス市場推計・予測、2018年～2030年
• 医薬品
  • 医薬品市場推計・予測、2018年～2030年
  • 全身性ステロイド
  • 抗ウイルス薬
  • 血管拡張薬
  • その他

第6章 難聴疾患治療 - 疾患タイプ別セグメント分析、2018年～2030年

• 難聴疾患治療市場シェア、疾患タイプ別、2018年および2030年
• 伝音難聴
  • 伝音難聴市場推計・予測、2018年～2030年
• 混合型感音性難聴
  • 混合型感音性難聴市場推計・予測、2018年～2030年
• 混合（伝導性および感音性）
  • 混合

第7章 難聴疾患治療市場セグメント分析、最終用途別、2018年～2030年

• 病院
  • 病院市場推計・予測、2018年～2030年
  • 耳鼻科クリニック市場推計・予測、2018年～2030年
  • 外来診療所市場推計・予測、2018年～2030年

第8章 難聴疾患治療市場：- 地域別セグメント分析、2018年～2030年

• 定義と範囲
• 北米
  • 北米、 SWOT分析
  • 米国
  • カナダ
• 欧州
  • 欧州、 SWOT分析
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • スウェーデン
  • デンマーク
  • ノルウェー
  • その他の欧州
• アジア太平洋
  • アジア太平洋、 SWOT分析
  • インド
  • 中国
  • 日本
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ラテンアメリカ、 SWOT分析
  • メキシコ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカ、 SWOT分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 公開会社
  • 企業の市況分析
  • 競合ダッシュボード分析
  • 戦略的枠組み
• 非公開会社
  • 主要な新興企業/テクノロジーディスラプター/イノベーターのリスト
  • 地域ネットワークマップ
• 企業プロファイル
  • Novartis Ag
  • Otonomy, Inc
  • Acousia Therapeutics Gmbh
  • Sensorion
  • Pipeline Therapeutics
  • Frequency Therapeutics
  • Astellas Pharma Inc
  • Audina Hearing Instruments, Inc.
  • Ws Audiology A/S
  • Audifon Gmbh &Co. Kg

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviation
• Table 3 List of Parameters
• Table 4 List of Distributors
• Table 5 Global Hearing Loss Disease Treatment Market, By Region, 2018 - 2030 (USD Million)
• Table 6 Global Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 7 Global Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 8 Global Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 9 North America Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 10 North America Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 11 North America Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 12 North America Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 13 U.S. Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 14 U.S. Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 15 U.S. Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 16 Canada Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 17 Canada Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 18 Canada Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 19 Europe Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 20 Europe Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 21 Europe Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 22 Europe Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 23 Germany Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 24 Germany Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 25 Germany Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 26 U.K. Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 27 U.K. Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 28 U.K. Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 29 France Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 30 France Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 31 France Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 32 Italy Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 33 Italy Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 34 Italy Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 35 Spain Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 36 Spain Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 37 Spain Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 38 Denmark Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 39 Denmark Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 40 Denmark Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 41 Sweden Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 42 Sweden Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 43 Sweden Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 44 Norway Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 45 Norway Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 46 Norway Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 51 Japan Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 52 Japan Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 53 Japan Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 54 China Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 55 China Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 56 China Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 57 India Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 58 India Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 59 India Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 60 South Korea Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 61 South Korea Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 62 South Korea Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 63 Australia Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 64 Australia Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 65 Australia Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 66 Thailand Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 67 Thailand Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 68 Thailand Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 69 Latin America Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 70 Latin America Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 71 Latin America Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 72 Latin America Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 73 Brazil Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 74 Brazil Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 75 Brazil Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 76 Mexico Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 77 Mexico Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 78 Mexico Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 79 Argentina Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 80 Argentina Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 81 Argentina Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 83 Middle East & Africa Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 84 Middle East & Africa Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 85 Middle East & Africa Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 89 South Africa Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 90 South Africa Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 91 South Africa Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 92 UAE Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 93 UAE Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 94 UAE Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)
• Table 95 Kuwait Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 96 Kuwait Hearing Loss Disease Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
• Table 97 Kuwait Hearing Loss Disease Treatment Market, By End-user, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value chain based sizing & Forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market summary
• Fig. 8 Market trends & outlook
• Fig. 9 Market segmentation & scope
• Fig. 10 Market driver relevance analysis (Current & future impact)
• Fig. 11 Market restraint relevance analysis (Current & future impact)
• Fig. 12 Penetration & growth prospect mapping
• Fig. 13 Hearing Loss disease treatment market - PESTLE analysis
• Fig. 14 Porter's Five Forces Analysis
• Fig. 15 Hearing Loss disease treatment market outlook key takeaways
• Fig. 16 Hearing Loss disease treatment market: Product movement analysis
• Fig. 17 Global hearing loss disease treatment market, by product, 2018 - 2030 (USD Million)
• Fig. 18 Global hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 19 Global devices market, 2018 - 2030 (USD Million)
• Fig. 20 Global drugs market, 2018 - 2030 (USD Million)
• Fig. 21 Global systemic steroids market, 2018 - 2030 (USD Million)
• Fig. 22 Global antiviral medication market, 2018 - 2030 (USD Million)
• Fig. 23 Global vasodilators market, 2018 - 2030 (USD Million)
• Fig. 24 Global hearing loss disease treatment market: Disease type movement analysis
• Fig. 25 Global hearing loss disease treatment market, by disease type, 2018 - 2030 (USD Million)
• Fig. 26 Global conductive hearing loss market, 2018 - 2030 (USD Million)
• Fig. 27 Global sensorineural hearing loss market, 2018 - 2030 (USD Million)
• Fig. 28 Global mixed market, 2018 - 2030 (USD Million)
• Fig. 29 Global hearing loss disease treatment market: End-user movement analysis
• Fig. 30 Global hearing loss disease treatment market, by end-user, 2018 - 2030 (USD Million)
• Fig. 31 Global otology clinics market, 2018 - 2030 (USD Million)
• Fig. 32 Global hospitals market, 2018 - 2030 (USD Million)
• Fig. 33 Global ambulatory clinics market, 2018 - 2030 (USD Million)
• Fig. 34 Regional market: Key takeaways
• Fig. 35 Hearing loss disease treatment market regional outlook, 2018 & 2030
• Fig. 36 North America hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 37 U.S. hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 38 Canada hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 39 Europe hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 40 Germany hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 41 U.K. hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 42 France hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 43 Italy hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 44 Spain hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 45 Denmark hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 46 Sweden hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 47 Norway hearing loss disease treatment market, 2018 - 2030 (USD Million
• Fig. 48 Asia Pacific hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 49 Japan hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 50 China hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 51 India hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 52 South Korea hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 53 Australia hearing loss disease treatment market, 2018 - 2030 (USD Million
• Fig. 54 Thailand hearing loss disease treatment market, 2018 - 2030 (USD Million
• Fig. 55 Latin America hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 56 Brazil hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 57 Mexico hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 58 Argentina hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 59 Middle East Africa hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 60 South Africa hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 61 Saudi Arabia hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 62 UAE hearing loss disease treatment market, 2018 - 2030 (USD Million)
• Fig. 63 Kuwait hearing loss disease treatment market, 2018 - 2030 (USD Million
• Fig. 64 Strategy frameworks

Hearing Loss Disease Treatment Market Growth & Trends:

The global hearing loss disease treatment market size is expected to reach USD 19.36 billion by 2030, registering a CAGR of 5.25% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth is attributed to the global rise in disease burden, initiatives undertaken by government and private organizations to spread awareness among people, and the growing geriatric population in the world. Furthermore, the increasing number of clinical pipeline drugs and advancements with auditory devices offer lucrative opportunities for industry growth. The world is witnessing an increasing prevalence of hearing loss cases, which is the key factor driving the industry's growth.

For instance, according to the WHO reports, in 2021, over 5% of the world's population, or around 430 million people, require rehabilitation to manage their listening disability. Moreover, by 2050, nearly 2.5 billion people are estimated to be impacted by listening impairment across the globe. As per the report, low- and middle-income countries account for 80% of people suffering from a disability. Aging has further led to an increase in the prevalence of the disease. Globally, approximately 25% of people aged 60 years are affected by hearing loss. Therefore, the rising disease cases increase the demand for treatment and drive the space. The space has the presence of a robust clinical trial pipeline, which is expected to offer better treatment options in the coming years.

This can be anticipated due to the presence of more than 45 therapies at different phases of clinical investigation. For instance, Sound Pharmaceuticals' Ebselen and Sensorion's SENS-401 are under phase 3 clinical studies indicated for the treatment of Meniere's Disease and sensorineural hearing loss, respectively. Similarly, in June 2022, Pipeline Therapeutics' phase 2 drug, PIPE-505 is being evaluated for sensorineural hearing loss. Therefore, the launch of new treatment options in the coming years is expected to offer a lucrative opportunity for the industry. Rising technological advancements, such as AI-associated innovations, in auditory products, are boosting the industry.

The launch of products with advanced features like operating through smartphones and rechargeable & waterproof devices is enhancing customer experience. For instance, in June 2022, GN Hearing launched Custom made by Resound, a chargeable hearing aid that supports wireless streaming from Android and iOS. Key players are implementing strategic initiatives, such as new launches, collaborations, agreements, and financial investments, which are further driving the industry. For instance, in April 2022, Autigen entered into a collaboration and licensing agreement with Boehringer Ingelheim to develop advanced therapies for people suffering from sensorineural conditions. Similarly, in September 2022, Fennec Pharmaceuticals announced the FDA approval for Pedmarkto prevents hearing loss in pediatric patients going through chemotherapy.

Hearing Loss Disease Treatment Market Report Highlights:

• The devices segment dominated the industry in 2023 and accounted for the maximum share of more than 90.65% of the overall revenue. This can be attributed to technological advancements in devices, high prevalence coupled with the rising benefits of devices.
• The drugs segment is estimated to register the fastest CAGR over the forecast period due to the launch of new therapeutic products. Drugs are available for several types of hearing problems.
• The sensorineural hearing loss segment dominated the industry in 2023 and accounted for the maximum share of more than 57.04% of the total revenue and is estimated to be the fastest growing segment over the forecast period.
• The otology clinics end-user segment, in 2023, accounted for the second-highest share of 45.18% of the overall revenue.
• Asia Pacific is expected to be the fastest-growing region from 2024 to 2030 due to the rising number of target patients and funding support to major players in the region.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Market Segmentation & Scope
  • 1.1.1 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 Gvr's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
• 1.7 Global Market: CAGR Calculation
• 1.8 Research Assumptions
• 1.9 List of Secondary Sources
• 1.10 List of Primary Sources
• 1.11 Objectives
  • 1.11.1 Objective 1:
  • 1.11.2 Objective 2:
• 1.12 List Of Abbreviations

Chapter 2 Market Definitions

Chapter 3 Executive Summary

• 3.1 Market Summary

Chapter 4 Global Hearing Loss Disease Treatment Market Variables, Trends, & Scope

• 4.1 Hearing Loss Disease Treatment Market Lineage Outlook
  • 4.1.1 Parent Market Outlook
• 4.2 Penetration and Growth Prospect Mapping
• 4.3 Regulatory Framework
• 4.4 Market Driver Analysis
  • 4.4.1 Rising Prevalence Of Hearing Loss
  • 4.4.2 Strong R&D Pipeline
  • 4.4.3 Rising Awarness Amoung People
• 4.5 Market Restraint Analysis
  • 4.5.1 Poor Reimbursement Facilities In Low - And Middle-Income Countries
• 4.6 Porter's Five Forces Analysis
• 4.7 Pipeline Analysis

Chapter 5 Hearing Loss Disease Treatment Market - Segment Analysis, By Product, 2018 - 2030 (USD Million)

• 5.1 Global Hearing Loss Disease Treatment Market: Product Movement Analysis
• 5.2. Devices
  • 5.2.1. Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.3. Drugs
  • 5.3.1. Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.3.2 Systemic Steroids
    • 5.3.2.1 Systemic Steroids Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.3.3 Antiviral Medication
    • 5.3.3.1 Antiviral Medication Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.3.4 Vasodilators
    • 5.3.4.1 Vasodilators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.3.5 Others
    • 5.3.5.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Hearing Loss Disease Treatment - Segment Analysis, By Disease Type, 2018 - 2030 (USD Million)

• 6.1. Hearing Loss Disease Treatment Market Share, By Disease Type, 2018 & 2030
• 6.2. Conductive Hearing Loss
  • 6.2.1. Conductive Hearing Loss Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.3. Sensorineural Hearing Loss Mixed
  • 6.3.1. Sensorineural Hearing Loss Mixed Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.3. Mixed (Conductive And Sensorineural)
  • 6.3.1. Mixed (Conductive And Sensorineural) Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Hearing Loss Disease Treatment Market- Segment Analysis, By End-User, 2018 - 2030 (USD Million)

• 7.1. Hospitals
  • 7.1.1 Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.2. Otology Clinics, 2018 - 2030
  • 7.2.1 Otology Clinics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.3. Ambulatory Clinics, 2018 - 2030
  • 7.3.1 Ambulatory Clinics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Hearing Loss Disease Treatment Market: - Segment Analysis, by Region, 2018 - 2030 (USD Million)

• 8.1 Definition & Scope
• 8.2 North America
  • 8.2.1 North America, SWOT Analysis
  • 8.2.2 U.S.
    • 8.2.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.2.2.2 Key Country Dynamics
    • 8.2.2.3 Target Disease Prevalence
    • 8.2.2.4 Competitive Scenario
    • 8.2.2.5 Regulatory Framework
    • 8.2.2.6 Reimbursment Scenario
  • 8.2.3 Canada
    • 8.2.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.2.3.2 Key Country Dynamics
    • 8.2.3.3 Target Disease Prevalence
    • 8.2.3.4 Competitive Scenario
    • 8.2.3.5 Regulatory Framework
    • 8.2.3.6 Reimbursment Scenario
• 8.3 Europe
  • 8.3.1 Europe, SWOT Analysis
  • 8.3.2 U.K.
    • 8.3.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.2.2 Key Country Dynamics
    • 8.3.2.3 Target Disease Prevalence
    • 8.3.2.4 Competitive Scenario
    • 8.3.2.5 Regulatory Framework
    • 8.3.2.6 Reimbursment Scenario
  • 8.3.3 Germany
    • 8.3.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.3.2 Key Country Dynamics
    • 8.3.3.3 Target Disease Prevalence
    • 8.3.3.4 Competitive Scenario
    • 8.3.3.5 Regulatory Framework
    • 8.3.3.6 Reimbursment Scenario
  • 8.3.4 France
    • 8.3.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.4.2 Key Country Dynamics
    • 8.3.4.3 Target Disease Prevalence
    • 8.3.4.4 Competitive Scenario
    • 8.3.4.5 Regulatory Framework
    • 8.3.4.6 Reimbursment Scenario
  • 8.3.5 Italy
    • 8.3.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.5.2 Key Country Dynamics
    • 8.3.5.3 Target Disease Prevalence
    • 8.3.5.4 Competitive Scenario
    • 8.3.5.5 Regulatory Framework
    • 8.3.5.6 Reimbursment Scenario
  • 8.3.6 Spain
    • 8.3.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.6.2 Key Country Dynamics
    • 8.3.6.3 Target Disease Prevalence
    • 8.3.6.4 Competitive Scenario
    • 8.3.6.5 Regulatory Framework
    • 8.3.6.6 Reimbursment Scenario
  • 8.3.7 Sweden
    • 8.3.7.1 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.7.2 Key Country Dynamics
    • 8.3.7.3 Target Disease Prevalence
    • 8.3.7.4 Competitive Scenario
    • 8.3.7.5 Regulatory Framework
    • 8.3.7.6 Reimbursment Scenario
  • 8.3.8 Denmark
    • 8.3.8.1 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.8.2 Key Country Dynamics
    • 8.3.8.3 Target Disease Prevalence
    • 8.3.8.4 Competitive Scenario
    • 8.3.8.5 Regulatory Framework
    • 8.3.8.6 Reimbursment Scenario
  • 8.3.9 Norway
    • 8.3.9.1 Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.9.2 Key Country Dynamics
    • 8.3.9.3 Target Disease Prevalence
    • 8.3.9.4 Competitive Scenario
    • 8.3.9.5 Regulatory Framework
    • 8.3.9.6 Reimbursment Scenario
  • 8.3.10 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Asia Pacific, SWOT Analysis
  • 8.4.2 India
    • 8.4.2.1 India market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.2.2 Key Country Dynamics
    • 8.4.2.3 Target Disease Prevalence
    • 8.4.2.4 Competitive Scenario
    • 8.4.2.5 Regulatory Framework
    • 8.4.2.6 Reimbursment Scenario
  • 8.4.3 China
    • 8.4.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.3.2 Key Country Dynamics
    • 8.4.3.3 Target Disease Prevalence
    • 8.4.3.4 Competitive Scenario
    • 8.4.3.5 Regulatory Framework
    • 8.4.3.6 Reimbursment Scenario
  • 8.4.4 Japan
    • 8.4.4.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.4.2 Key Country Dynamics
    • 8.4.4.3 Target Disease Prevalence
    • 8.4.4.4 Competitive Scenario
    • 8.4.4.5 Regulatory Framework
    • 8.4.4.6 Reimbursment Scenario
  • 8.4.5 Australia
    • 8.4.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.5.2 Key Country Dynamics
    • 8.4.5.3 Target Disease Prevalence
    • 8.4.5.4 Competitive Scenario
    • 8.4.5.5 Regulatory Framework
    • 8.4.5.6 Reimbursment Scenario
  • 8.4.6 South Korea
    • 8.4.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.6.2 Key Country Dynamics
    • 8.4.6.3 Target Disease Prevalence
    • 8.4.6.4 Competitive Scenario
    • 8.4.6.5 Regulatory Framework
    • 8.4.6.6 Reimbursment Scenario
  • 8.4.7 Thailand
    • 8.4.7.1 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.7.2 Key Country Dynamics
    • 8.4.7.3 Target Disease Prevalence
    • 8.4.7.4 Competitive Scenario
    • 8.4.7.5 Regulatory Framework
    • 8.4.7.6 Reimbursment Scenario
• 8.5 Latin America
  • 8.5.1 Latin America, SWOT Analysis
  • 8.5.2 Mexico
    • 8.5.2.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.2.2 Key Country Dynamics
    • 8.5.2.3 Target Disease Prevalence
    • 8.5.2.4 Competitive Scenario
    • 8.5.2.5 Regulatory Framework
    • 8.5.2.6 Reimbursment Scenario
  • 8.5.3 Brazil
    • 8.5.3.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.3.2 Key Country Dynamics
    • 8.5.3.3 Target Disease Prevalence
    • 8.5.3.4 Competitive Scenario
    • 8.5.3.5 Regulatory Framework
    • 8.5.3.6 Reimbursment Scenario
  • 8.5.4 Argentina
    • 8.5.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.4.2 Key Country Dynamics
    • 8.5.4.3 Target Disease Prevalence
    • 8.5.4.4 Competitive Scenario
    • 8.5.4.5 Regulatory Framework
    • 8.5.4.6 Reimbursment Scenario
• 8.6 MEA
  • 8.6.1 Middle East & Africa, SWOT Analysis
  • 8.6.2 South Africa
    • 8.6.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.2.2 Key Country Dynamics
    • 8.6.2.3 Target Disease Prevalence
    • 8.6.2.4 Competitive Scenario
    • 8.6.2.5 Regulatory Framework
    • 8.6.2.6 Reimbursment Scenario
  • 8.6.3 Saudi Arabia
    • 8.6.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3.2 Key Country Dynamics
    • 8.6.3.3 Target Disease Prevalence
    • 8.6.3.4 Competitive Scenario
    • 8.6.3.5 Regulatory Framework
    • 8.6.3.6 Reimbursment Scenario
  • 8.6.4 UAE
    • 8.6.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.4.2 Key Country Dynamics
    • 8.6.4.3 Target Disease Prevalence
    • 8.6.4.4 Competitive Scenario
    • 8.6.4.5 Regulatory Framework
    • 8.6.4.6 Reimbursment Scenario
  • 8.6.5 Kuwait
    • 8.6.5.1 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.5.2 Key Country Dynamics
    • 8.6.5.3 Target Disease Prevalence
    • 8.6.5.4 Competitive Scenario
    • 8.6.5.5 Regulatory Framework
    • 8.6.5.6 Reimbursment Scenario

Chapter 9 Competitive Landscape

• 9.1 Public Companies
  • 9.1.1 Company Market Position Analysis
  • 9.1.2 Competitive Dashboard Analysis
  • 9.1.3 Strategic Framework
• 9.2 Private Companies
  • 9.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
  • 9.2.2 Regional Network Map
• 9.3 Company Profiles
  • 9.3.1 Novartis Ag
    • 9.3.1.1 Company Overview
    • 9.3.1.2 Financial Performance
    • 9.3.1.3 Product Benchmarking
    • 9.3.1.4 Strategic Initiatives
  • 9.3.2 Otonomy, Inc
    • 9.3.2.1 Company Overview
    • 9.3.2.2 Financial Performance
    • 9.3.2.3 Product Benchmarking
    • 9.3.2.4 Strategic Initiatives
  • 9.3.3 Acousia Therapeutics Gmbh
    • 9.3.3.1 Company Overview
    • 9.3.3.2 Financial Performance
    • 9.3.3.3 Product Benchmarking
    • 9.3.3.4 Strategic Initiatives
  • 9.3.4 Sensorion
    • 9.3.4.1 Company Overview
    • 9.3.4.2 Financial Performance
    • 9.3.4.3 Product Benchmarking
    • 9.3.4.4 Strategic Initiatives
  • 9.3.5 Pipeline Therapeutics
    • 9.3.5.1 Company Overview
    • 9.3.5.2 Financial Performance
    • 9.3.5.3 Product Benchmarking
    • 9.3.5.4 Strategic Initiatives
  • 9.3.6 Frequency Therapeutics
    • 9.3.6.1 Company Overview
    • 9.3.6.2 Financial Performance
    • 9.3.6.3 Product Benchmarking
    • 9.3.6.4 Strategic Initiatives
  • 9.3.7 Astellas Pharma Inc
    • 9.3.7.1 Company Overview
    • 9.3.7.2 Financial Performance
    • 9.3.7.3 Product Benchmarking
    • 9.3.7.4 Strategic Initiatives
  • 9.3.8 Audina Hearing Instruments, Inc.
    • 9.3.8.1 Company Overview
    • 9.3.8.2 Financial Performance
    • 9.3.8.3 Product Benchmarking
    • 9.3.8.4 Strategic Initiatives
  • 9.3.9 Ws Audiology A/S
    • 9.3.9.1 Company Overview
    • 9.3.9.2 Financial Performance
    • 9.3.9.3 Product Benchmarking
    • 9.3.9.4 Strategic Initiatives
  • 9.3.10 Audifon Gmbh & Co. Kg
    • 9.3.10.1 Company Overview
    • 9.3.10.2 Financial Performance
    • 9.3.10.3 Product Benchmarking
    • 9.3.10.4 Strategic Initiatives